Alois B. Lang
Corporate Officer/Principal chez University of Bern
Postes actifs de Alois B. Lang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of Bern | Corporate Officer/Principal | - | - |
Historique de carrière de Alois B. Lang
Anciens postes connus de Alois B. Lang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GENEURO SA | Corporate Officer/Principal | - | 31/12/2018 |
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Directeur Technique/Scientifique/R&D | 02/09/2006 | - |
| Fondateur | 02/09/2006 | - |
Formation de Alois B. Lang
| Swiss Federal Institute of Technology | Doctorate Degree |
Statistiques
Internationale
| Suisse | 5 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENEURO SA | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
- Bourse
- Insiders
- Alois B. Lang
- Expérience
